Senores Pharmaceuticals Limited (NSE:SENORES)

Market Cap	36.12B +43.0%
Revenue (ttm)	5.53B +43.2%
Net Income	1.02B +79.3%
EPS	22.43 +40.3%
Shares Out	46.05M
PE Ratio	34.96
Forward PE	26.78
Dividend	n/a
Ex-Dividend Date	n/a

Volume	213,568
Average Volume	151,262
Open	768.00
Previous Close	773.55
Day's Range	741.90 - 789.95
52-Week Range	440.30 - 876.50
Beta	n/a
RSI	54.81
Earnings Date	May 30, 2026

About Senores Pharmaceuticals

Senores Pharmaceuticals Limited develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally. It offers pharmaceutical solutions, such as analgesic/antipyretic, anesthetics and allied products, antibacterial/antibiotic, antiviral, antifungal, antioxidants, antineoplastic, blood line, cardiovascular, neurology, antacid, and vitamin and mineral preparation solutions; and analgesic/anti-inflammatory/antipyretic, anti-diabetic, antimalarial, neutral supp...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 2017
• Employees: 194
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SENORES

Financial Performance

In fiscal year 2025, Senores Pharmaceuticals's revenue was 3.98 billion, an increase of 85.65% compared to the previous year's 2.15 billion. Earnings were 585.60 million, an increase of 86.20%.